These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 34181109)

  • 1. PSMA: a game changer in the diagnosis and treatment of advanced prostate cancer.
    Parsi M; Desai MH; Desai D; Singhal S; Khandwala PM; Potdar RR
    Med Oncol; 2021 Jun; 38(8):89. PubMed ID: 34181109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Theranostics for Advanced Prostate Cancer: Current Indications and Future Developments.
    Farolfi A; Fendler W; Iravani A; Haberkorn U; Hicks R; Herrmann K; Walz J; Fanti S
    Eur Urol Oncol; 2019 Mar; 2(2):152-162. PubMed ID: 31017091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate specific membrane antigen (PSMA) ligands for diagnosis and therapy of prostate cancer.
    Barrio M; Fendler WP; Czernin J; Herrmann K
    Expert Rev Mol Diagn; 2016 Nov; 16(11):1177-1188. PubMed ID: 27679869
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    von Eyben FE; Picchio M; von Eyben R; Rhee H; Bauman G
    Eur Urol Focus; 2018 Sep; 4(5):686-693. PubMed ID: 28753806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [PSMA-based theranostics for prostate cancer : From imaging to treatment].
    Ilhan H; la Fougère C; Krause BJ
    Urologe A; 2020 May; 59(5):617-625. PubMed ID: 32377764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PSMA Ligands for PET Imaging of Prostate Cancer.
    Schwarzenboeck SM; Rauscher I; Bluemel C; Fendler WP; Rowe SP; Pomper MG; Afshar-Oromieh A; Herrmann K; Eiber M
    J Nucl Med; 2017 Oct; 58(10):1545-1552. PubMed ID: 28687599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate-specific Membrane Antigen PET: Clinical Utility in Prostate Cancer, Normal Patterns, Pearls, and Pitfalls.
    Hofman MS; Hicks RJ; Maurer T; Eiber M
    Radiographics; 2018; 38(1):200-217. PubMed ID: 29320333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical PSMA expression patterns of primary prostate cancer tissue are associated with the detection rate of biochemical recurrence with
    Ferraro DA; Rüschoff JH; Muehlematter UJ; Kranzbühler B; Müller J; Messerli M; Husmann L; Hermanns T; Eberli D; Rupp NJ; Burger IA
    Theranostics; 2020; 10(14):6082-6094. PubMed ID: 32483440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The utility of radiolabeled PSMA ligands for tumor imaging.
    Shahrokhi P; Masteri Farahani A; Tamaddondar M; Rezazadeh F
    Chem Biol Drug Des; 2022 Jan; 99(1):136-161. PubMed ID: 34472217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cold Kit for Prostate-Specific Membrane Antigen (PSMA) PET Imaging: Phase 1 Study of
    Hofman MS; Eu P; Jackson P; Hong E; Binns D; Iravani A; Murphy D; Mitchell C; Siva S; Hicks RJ; Young JD; Blower PJ; Mullen GE
    J Nucl Med; 2018 Apr; 59(4):625-631. PubMed ID: 28986512
    [No Abstract]   [Full Text] [Related]  

  • 11. A prospective randomized multicentre study of the impact of gallium-68 prostate-specific membrane antigen (PSMA) PET/CT imaging for staging high-risk prostate cancer prior to curative-intent surgery or radiotherapy (proPSMA study): clinical trial protocol.
    Hofman MS; Murphy DG; Williams SG; Nzenza T; Herschtal A; Lourenco RA; Bailey DL; Budd R; Hicks RJ; Francis RJ; Lawrentschuk N
    BJU Int; 2018 Nov; 122(5):783-793. PubMed ID: 29726071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PSMA PET and Radionuclide Therapy in Prostate Cancer.
    Bouchelouche K; Turkbey B; Choyke PL
    Semin Nucl Med; 2016 Nov; 46(6):522-535. PubMed ID: 27825432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological evaluation of copper-64 radiolabeled [DUPA-6-Ahx-(NODAGA)-5-Ava-BBN(7-14)NH2], a novel bivalent targeting vector having affinity for two distinct biomarkers (GRPr/PSMA) of prostate cancer.
    Bandari RP; Jiang Z; Reynolds TS; Bernskoetter NE; Szczodroski AF; Bassuner KJ; Kirkpatrick DL; Rold TL; Sieckman GL; Hoffman TJ; Connors JP; Smith CJ
    Nucl Med Biol; 2014 Apr; 41(4):355-63. PubMed ID: 24508213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging and therapy in prostate cancer using prostate specific membrane antigen radioligands.
    Naik M; Khan SR; Lewington V; Challapalli A; Eccles A; Barwick TD
    Br J Radiol; 2024 Aug; 97(1160):1391-1404. PubMed ID: 38733571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneous Flare in Prostate-specific Membrane Antigen Positron Emission Tomography Tracer Uptake with Initiation of Androgen Pathway Blockade in Metastatic Prostate Cancer.
    Aggarwal R; Wei X; Kim W; Small EJ; Ryan CJ; Carroll P; Cooperberg M; Evans MJ; Hope T
    Eur Urol Oncol; 2018 May; 1(1):78-82. PubMed ID: 31100231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current application and future perspectives of prostate specific membrane antigen PET imaging in prostate cancer.
    Ceci F; Castellucci P; Fanti S
    Q J Nucl Med Mol Imaging; 2019 Mar; 63(1):7-18. PubMed ID: 29521482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate-specific membrane antigen targeted PET imaging for prostate cancer recurrence.
    Ferdinandus J; Fendler WP; Hadaschik B; Herrmann K
    Curr Opin Urol; 2020 Sep; 30(5):635-640. PubMed ID: 32732621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New Strategies in Prostate Cancer: Prostate-Specific Membrane Antigen (PSMA) Ligands for Diagnosis and Therapy.
    Haberkorn U; Eder M; Kopka K; Babich JW; Eisenhut M
    Clin Cancer Res; 2016 Jan; 22(1):9-15. PubMed ID: 26728408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effects of Monosodium Glutamate on PSMA Radiotracer Uptake in Men with Recurrent Prostate Cancer: A Prospective, Randomized, Double-Blind, Placebo-Controlled Intraindividual Imaging Study.
    Harsini S; Saprunoff H; Alden T; Mohammadi B; Wilson D; Bénard F
    J Nucl Med; 2021 Jan; 62(1):81-87. PubMed ID: 32385167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in prostate-specific membrane antigen PET of prostate cancer.
    Bouchelouche K; Choyke PL
    Curr Opin Oncol; 2018 May; 30(3):189-196. PubMed ID: 29465429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.